Testing effectiveness (Phase 2)Ended earlyNCT01267240
What this trial is testing
Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Who this might be right for
Paranasal Sinus Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+14 more
National Cancer Institute (NCI) 25